Sidhaant Multispeciality Hospital And Research Center Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 31-07-2024
- Paid Up Capital ₹ 0.50 M
as on 31-07-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -8.99%
(FY 2023)
- Profit -8.72%
(FY 2023)
- Ebitda -5.30%
(FY 2023)
- Net Worth 30.05%
(FY 2023)
- Total Assets -11.60%
(FY 2023)
About Sidhaant Multispeciality Hospital And Research Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vinod Bhaargava, Hemant Tripathi, and Jyoti Gupta serve as directors at the Company.
- CIN/LLPIN
U73100MP2017PTC043054
- Company No.
043054
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Gwalior, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sidhaant Multispeciality Hospital And Research Center?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Bhaargava  | Director | 06-Apr-2017 | Current |
| Hemant Tripathi | Director | 06-Apr-2017 | Current |
| Jyoti Gupta | Director | 23-Oct-2020 | Current |
Financial Performance of Sidhaant Multispeciality Hospital And Research Center.
Sidhaant Multispeciality Hospital And Research Center Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.99% decrease. The company also saw a slight decrease in profitability, with a 8.72% decrease in profit. The company's net worth Soared by an impressive increase of 30.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sidhaant Multispeciality Hospital And Research Center?
In 2023, Sidhaant Multispeciality Hospital And Research Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sidhaant Multispeciality Hospital And Research Center?
Unlock and access historical data on people associated with Sidhaant Multispeciality Hospital And Research Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sidhaant Multispeciality Hospital And Research Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sidhaant Multispeciality Hospital And Research Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
